Ultra-sensitive detection of Mycobacterium leprae: DNA extraction and PCR assays.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
25
11
2019
accepted:
24
04
2020
revised:
05
06
2020
pubmed:
27
5
2020
medline:
17
7
2020
entrez:
27
5
2020
Statut:
epublish
Résumé
Leprosy urgently needs a precise and early diagnostic tool. The sensitivity of the direct (bacilli staining, Mycobacterium leprae DNA) and indirect (antibody levels, T cell assays) diagnostics methods vary based on the clinical form. Recently, PCR-based M. leprae DNA detection has been shown to differentially diagnose leprosy from other dermatological conditions. However, accuracy can still be improved, especially for use with less invasive clinical samples. We tested different commercial DNA extraction kits: DNeasy Blood & Tissue, QIAamp DNA Microbiome, Maxwell 16 DNA Purification, PowerSoil DNA Isolation; as well as in-house phenol-chloroform and Trizol/FastPrep methods. Extraction was performed on M. leprae-infected mouse footpads and different clinical samples of leprosy patients (skin biopsies and scrapings, lesion, oral and nasal swabs, body hair, blood on FTA cards, peripheral whole blood). We observed that the Microbiome kit was able to enrich for mycobacterial DNA, most likely due the enzymatic digestion cocktail along with mechanical disruption involved in this method. Consequently, we had a significant increase in sensitivity in skin biopsies from paucibacillary leprosy patients using a duplex qPCR targeting 16S rRNA (M. leprae) and 18S rRNA (mammal) in the StepOnePlus system. Our data showed that the presence of M. leprae DNA was best detected in skin biopsies and skin scrapings, independent of the extraction method or the clinical form. For multibacillary patients, detection of M. leprae DNA in nasal swabs indicates the possibility of having a much less invasive sample that can be used for the purposes of DNA sequencing for relapse analysis and drug resistance monitoring. Overall, DNA extracted with the Microbiome kit presented the best bacilli detection rate for paucibacillary cases, indicating that investments in extraction methods with mechanical and DNA digestion should be made.
Identifiants
pubmed: 32453754
doi: 10.1371/journal.pntd.0008325
pii: PNTD-D-19-01955
pmc: PMC7274454
doi:
Substances chimiques
DNA, Bacterial
0
RNA, Bacterial
0
RNA, Ribosomal, 16S
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0008325Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Braz J Infect Dis. 2017 Jan - Feb;21(1):71-78
pubmed: 27888674
Lancet Infect Dis. 2017 Sep;17(9):e298-e305
pubmed: 28693856
Jpn J Infect Dis. 2011;64(3):246-8
pubmed: 21617312
Int J Lepr Other Mycobact Dis. 1966 Jul-Sep;34(3):255-73
pubmed: 5950347
Eur J Clin Microbiol Infect Dis. 2018 Oct;37(10):1863-1867
pubmed: 30008126
PLoS Negl Trop Dis. 2011 Oct;5(10):e1354
pubmed: 22022631
Clin Microbiol Rev. 2015 Jan;28(1):80-94
pubmed: 25567223
Int J Mycobacteriol. 2015 Dec;4(4):284-9
pubmed: 26964809
Ann Clin Microbiol Antimicrob. 2016 May 21;15(1):33
pubmed: 27209077
Clin Microbiol Infect. 2019 Feb;25(2):242-247
pubmed: 29730222
PLoS Negl Trop Dis. 2018 Jun 28;12(6):e0006532
pubmed: 29953440
PLoS Negl Trop Dis. 2014 Apr 10;8(4):e2655
pubmed: 24722358
Sci Rep. 2018 Nov 5;8(1):16321
pubmed: 30397210
Mem Inst Oswaldo Cruz. 2014 Nov;109(7):944-7
pubmed: 25411000
Clin Infect Dis. 2016 Dec 1;63(11):1412-1420
pubmed: 27558564
Rev Soc Bras Med Trop. 2008;41 Suppl 2:11-8
pubmed: 19618069
PLoS One. 2012;7(3):e33865
pubmed: 22457796
Sci Rep. 2019 Nov 13;9(1):16675
pubmed: 31723144
Clin Microbiol Infect. 2014 May;20(5):447-52
pubmed: 24033793
PLoS One. 2010 Aug 13;5(8):e11963
pubmed: 20730102
PLoS Negl Trop Dis. 2012;6(9):e1818
pubmed: 23029580
J Neurol Sci. 2017 Sep 15;380:187-190
pubmed: 28870564
PLoS Negl Trop Dis. 2016 Dec 27;10(12):e0005220
pubmed: 28027305
PLoS Negl Trop Dis. 2018 Dec 19;12(12):e0007001
pubmed: 30566440
Science. 2016 Nov 11;354(6313):744-747
pubmed: 27846605
Lancet Infect Dis. 2011 Jun;11(6):464-70
pubmed: 21616456
Int J Mycobacteriol. 2015 Mar;4(1):54-9
pubmed: 26655199
Lepr Rev. 2011 Dec;82(4):389-401
pubmed: 22439279
PLoS Negl Trop Dis. 2015 Jul 23;9(7):e0003936
pubmed: 26204525
PLoS Negl Trop Dis. 2019 Mar 5;13(3):e0007147
pubmed: 30835722
Braz J Med Biol Res. 2012 Feb;45(2):153-7
pubmed: 22286535
Clin Microbiol Infect. 2019 Nov;25(11):1315-1327
pubmed: 31158516
Lancet Infect Dis. 2004 Jun;4(6):337-48
pubmed: 15172342
J Clin Microbiol. 2006 Sep;44(9):3154-9
pubmed: 16954241